AgenT

About:

AgenT develops the first blood diagnosis to detect Alzheimer's disease from the asymptomatic stage.

Website: http://www.agent-biotech.com/

Twitter/X: agent_biotech

Top Investors: Creative Destruction Lab (CDL), Bernard Majoie

Description:

AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing an accurate blood diagnosis and the next generation of precision therapies to treat Alzheimer’s.

Total Funding Amount:

3.4M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2018-03-16

Contact Email:

hello(AT)agent-biotech.com

Founders:

Baptiste Billoir, Jerome Braudeau

Number of Employees:

1-10

Last Funding Date:

2021-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai